Ting Chang, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis (NCT06958939) | Ting Chang, MD | 2025-05-01 |
| Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis (NCT06371040) | Ting Chang, MD | 2024-07-12 |
Track Ting Chang, MD automatically
Every clearance here is in the API, with alerts when new ones post.